About Us

All work and no play made Jack a dull boy…. You’re no Jack and we at Cannabis After Dark certainly like to play. We are a nationally distributed print/digital publication that brings together talented and passionate artists, activist and writers -all with the goal of creating an interactive, community -centric publication for Cannabis enthusiasts. From our strain reviews to our culinary creations and fashion talk to music and artist highlights; our publication promises to illuminate the senses while  keeping you apprised of what’s going on through the world.  So join us at Cannabis -After Dark as we excite  the senses by expanding your horizons and keep you informed on all things cannabis. Because we all know, that ‘After Dark is when the real fun begins.’


4750 N Central Ave

Phoenix, AZ 85012

Contact details

Email: info@cannabisafterdark.com

Twitter: @quondon

Phone: 213.623.8219

New York To Allow Patients To Switch Opioids For Medical Cannabis

New York To Allow Patients To Switch Opioids For Medical Cannabis
July 13, 2018 cannabisafterdark

By Benjie Cooper

IG: @nuglifenews

YouTube: Lucid’s Vlog

Opioid overdose deaths rise in the 2000s

Opioid deaths in the United States have been on a steady climb since the late 1990s with a dramatic increase occurring around 2013. But in states where medical or recreational cannabis is available, there has been a noticeable decrease in opioid overdose fatalities.

The reduction in deaths is a trend that has not gone unnoticed by the New York Health Department which has announced its filing of emergency regulations to allow patients with opioid prescriptions to opt for medical marijuana instead. Additionally, the ordinance will enable people undergoing treatment for opioid addiction to qualify to use cannabis as a replacement.

“The opioid epidemic in New York State is an unprecedented crisis, and it is critical to ensure that providers have as many options as possible to treat patients in the most effective way,” said New York State Health Commissioner Dr. Howard Zucker in a statement. “As research indicates that marijuana can reduce the use of opioids, adding opioid use as a qualifying condition for medical marijuana has the potential to help save countless lives across the state.”

Image: New York State Department of Health

Dr. Howard Zucker

Opioid substitution will be added to a list of twelve other conditions that allow people to enroll in the state’s medicinal cannabis program including Parkinson’s disease, multiple sclerosis, HIV/AIDS, chronic pain, PTSD, epilepsy, Huntington’s disease, inflammatory bowel disease, spinal cord injury with spasticity, amyotrophic lateral sclerosis, neuropathy, and cancer.

The New York medical marijuana program has more than 62,000 patients enrolled, and 1,735 practitioners are certified to recommend cannabis for qualifying conditions.

Chart: Centers for Disease Control and Prevention
Image: New York State Department of Health


Source link